Literature DB >> 19663722

If cancer stem cells are resistant to current therapies, what's next?

Paola Marcato, Cheryl A Dean, Carman A Giacomantonio, Patrick W K Lee.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19663722     DOI： 10.2217/fon.09.58

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  2 in total

Review 1.  The role of human aldehyde dehydrogenase in normal and cancer stem cells.

Authors:  Irene Ma; Alison L Allan
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

2.  ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells.

Authors:  Dejan Vidovic; Thomas T Huynh; Prathyusha Konda; Cheryl Dean; Brianne M Cruickshank; Mohammad Sultan; Krysta M Coyle; Shashi Gujar; Paola Marcato
Journal:  Cell Death Differ       Date:  2019-06-13       Impact factor: 12.067
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.